Search

Wednesday 26 June 2024

LBT Innovations (ASX: LBT): Completes first sale of APAS® PharmaQC

Australian medical technology company LBT Innovations (ASX: LBT) has completed its first sale of APAS® PharmaQC to Thermo Fisher Scientific (Thermo Fisher), aiming to provide efficiencies and improve traceability within environmental monitoring workflows using AI | ASX announcement: https://announcements.asx.com.au/asxpdf/20240222/pdf/060pf49b9csjfg.pdf

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox